Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Innogenetics, Abbott, Behring Diagnostics GmbH, Boehringer Mannheim GmbH deal

Abbott received a non-exclusive worldwide license from Behring and Boehringer Mannheim to patents

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE